General discussion, page-20229

Zepbound is a competitor to ozempic and aimed at weight loss. Losing weight can definitely improve sleep apnea symptoms but it's certainly not a direct competitor to 42x.
imho, retail holders are meaningless and institutional investments are just around the corner. too many catalysts around the corner to keep this beast tamed, and I doubt we will see dumps after pumps going forward if results are as expected. Then again, this is incannex and we never know. GL to all involved